Journal
PLATELETS
Volume 17, Issue 5, Pages 340-343Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/09537100600757935
Keywords
pegylated-interferon; standard interferon; autoimmune thrombocytopenia; chronic hepatitis C
Categories
Ask authors/readers for more resources
Mild thrombocytopenia is a common adverse effect of interferon-alpha and pegylated interferon-alpha, largely ascribed to bone marrow suppression. Nevertheless, rare cases of autoimmune thrombocytopenia following standard or pegylated interferon treatment have been reported in the literature. In this report, we have presented a patient who developed an immunemediated thrombocytopenia during the course of therapy with pegylated interferon/ribavirin for hepatitis C virus infection. After cessation of pegylated interferon/ribavirin treatment, thrombocytopenia was treated successfully with danazol and intravenous gamma-globulin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available